NAXS Kallelse till årsstämma 2021

Aktieägarna i NAXS AB (publ), org.nr 556712-2972, med säte i Stockholm (”Bolaget” eller ”NAXS”), kallas härmed till årsstämma torsdagen den 11 mars 2021. Läs mer

Sambla och Advisa går samman och skapar en ledare inom digitala jämförelsetjänster för privatekonomi med Nordic Capital som ny huvudägare

Two of the leading independent online comparison sites for personal finance in the Nordic region, Sambla and Advisa, have today announced their intention to merge. The purpose is to further develop as a combined company to help more clients improve their personal finances by comparing terms on loans and insurance. Both companies have a very high level of customer satisfaction due to a modern user interface, strong and shared corporate values, and by bringing clear benefits to their clients. There is strong growth potential as the two companies support and complement each other very well. Nordic Capital becomes the majority owner and will actively support the new company in the next expansion phase. The goal is to be the best partner for customers, banks and lenders alike, and over time to become the Nordic region's leading digital comparison site for personal finance. Läs mer

NAXS Bokslutskommuniké 2020

Januari-december 2020 Resultat efter skatt uppgick till 24,1 (37,1) MSEK. Resultatet per aktie uppgick till 2,16 (3,24) SEK. Substansvärdet uppgick till ... Läs mer

NAXS har gjort ett investeringsåtagande till Equip Capital Fund I LP

NAXS har gjort ett investeringsåtagande om 20 MNOK gentemot private equity buyout fonden Equip Capital Fund I LP (”Equip” eller ”Fonden”). Läs mer

Nordic Capital investerar tillsammans med Astorg i Cytel, ett företag verksamt inom utformning av kliniska studier åt läkemedelsföretag

Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data  Nordic Capital and Astorg will actively support and accelerate Cytel’s next phase of growth and innovation, drawing on their extensive experience of investing in healthcare and technology Läs mer